SEC Form 4 · accession 0001127602-19-003741
CVS HEALTH Corp · CVS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Larry J Merlo
Officer — President and CEO · Director
Period of report
Feb 1, 2019
Accepted (ET)
Feb 4, 2019 · 4:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000064803
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 1, 2019 | M | 166,368 | $45.07 | A | 496,577 | D | |
| Common StockF2 | Feb 1, 2019 | S | 166,368 | $64.51 | D | 330,209 | D | |
| Common Stock | holding | — | — | — | 378,463 | I | By Trust As Beneficiary |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF3 | $45.07 | Feb 1, 2019 | M | 166,368 | D | Apr 2, 2013 | Apr 2, 2019 | Common Stock | 166,368 | 0 | D |
Explanation of responses
- F1All sales were effected pursuant to a Rule 10b5-1 plan.
- F2Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging from $62.91 and $65.29 per share.
- F3Option became exercisable in four equal annual installments, commencing 4/2/2013.